Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03233204
Title Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

neuroblastoma

childhood osteosarcoma

childhood ependymoma

non-Hodgkin lymphoma

Advanced Solid Tumor

Ewing sarcoma

hepatoblastoma

rhabdomyosarcoma

histiocytosis

childhood medulloblastoma

high grade glioma

Therapies

Olaparib

Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST